1,2,3-三甲基-5-硝基-苯 | 52414-95-6

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 1,2,3-三甲基-5-硝基-苯
• 英文名称: 3,4,5-trimethyl-1-nitrobenzene
• 英文别名: 1,2,3-trimethyl-5-nitro-benzene；1,2,3-Trimethyl-5-nitro-benzol；1-nitro-3,4,5-trimethylbenzene；1-Nitro-3,4,5-trimethyl-benzol；5-Nitro-1,2,3-trimethyl-benzol；5-Nitro-hemimellitol；1,2,3-Trimethyl-5-nitrobenzene
• CAS: 52414-95-6
• 化学式: C₉H₁₁NO₂
• 分子量: 165.192
• InChiKey: BEAGEKZOSQKTBW-UHFFFAOYSA-N

物化性质

• 熔点：
  69-71 °C
• 沸点：
  285.9±9.0 °C(Predicted)
• 密度：
  1.100±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.8
• 重原子数：
  12
• 可旋转键数：
  0
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.33
• 拓扑面积：
  45.8
• 氢给体数：
  0
• 氢受体数：
  2

安全信息

• 海关编码：
  2904209090

SDS

---

Section 1. IDENTIFICATION OF THE SUBSTANCE/MIXTURE
Product identifiers
Product name : 1-Nitro-3,4,5-trimethylbenzene
CAS-No. : 52414-95-6
Relevant identified uses of the substance or mixture and uses advised against
Identified uses : Laboratory chemicals, Manufacture of substances

---

Section 2. HAZARDS IDENTIFICATION
Classification of the substance or mixture
Not a hazardous substance or mixture according to Regulation (EC) No 1272/2008
This substance is not classified as dangerous according to Directive 67/548/EEC.
Label elements
The product does not need to be labelled in accordance with EC directives or respective national laws.
Other hazards - none

---

Section 3. COMPOSITION/INFORMATION ON INGREDIENTS
Substances
Formula : C9H11NO2
Molecular Weight : 165,19 g/mol

---

Section 4. FIRST AID MEASURES
Description of first aid measures
General advice
Consult a physician. Show this safety data sheet to the doctor in attendance.
If inhaled
If breathed in, move person into fresh air. If not breathing, give artificial respiration. Consult a physician.
In case of skin contact
Wash off with soap and plenty of water. Consult a physician.
In case of eye contact
Flush eyes with water as a precaution.
If swallowed
Never give anything by mouth to an unconscious person. Rinse mouth with water. Consult a physician.
Most important symptoms and effects, both acute and delayed
To the best of our knowledge, the chemical, physical, and toxicological properties have not been
thoroughly investigated.
Indication of any immediate medical attention and special treatment needed
no data available

---

Section 5. FIREFIGHTING MEASURES
Extinguishing media
Suitable extinguishing media
Use water spray, alcohol-resistant foam, dry chemical or carbon dioxide.
Special hazards arising from the substance or mixture
Carbon oxides, nitrogen oxides (NOx)
Advice for firefighters
Wear self contained breathing apparatus for fire fighting if necessary.
Further information
no data available

---

Section 6. ACCIDENTAL RELEASE MEASURES
Personal precautions, protective equipment and emergency procedures
Use personal protective equipment. Avoid dust formation. Avoid breathing vapors, mist or gas. Avoid
breathing dust.
Environmental precautions
Do not let product enter drains.
Methods and materials for containment and cleaning up
Pick up and arrange disposal without creating dust. Sweep up and shovel. Keep in suitable, closed
containers for disposal.
Reference to other sections
For disposal see section 13.

---

Section 7. HANDLING AND STORAGE
Precautions for safe handling
Avoid formation of dust and aerosols.
Provide appropriate exhaust ventilation at places where dust is formed.Normal measures for preventive fire
protection.
Conditions for safe storage, including any incompatibilities
Store in cool place. Keep container tightly closed in a dry and well-ventilated place.
Specific end uses
no data available

---

Section 8. EXPOSURE CONTROLS/PERSONAL PROTECTION
Control parameters
Components with workplace control parameters
Exposure controls
Appropriate engineering controls
Handle in accordance with good industrial hygiene and safety practice. Wash hands before breaks and
at the end of workday.
Personal protective equipment
Eye/face protection
Use equipment for eye protection tested and approved under appropriate government standards
such as NIOSH (US) or EN 166(EU).
Skin protection
Handle with gloves. Gloves must be inspected prior to use. Use proper glove removal technique
(without touching glove's outer surface) to avoid skin contact with this product. Dispose of
contaminated gloves after use in accordance with applicable laws and good laboratory practices.
Wash and dry hands.
The selected protective gloves have to satisfy the specifications of EU Directive 89/686/EEC and
the standard EN 374 derived from it.
Body Protection
Choose body protection in relation to its type, to the concentration and amount of dangerous
substances, and to the specific work-place., The type of protective equipment must be selected
according to the concentration and amount of the dangerous substance at the specific workplace.
Respiratory protection
Respiratory protection is not required. Where protection from nuisance levels of dusts are desired,
use type N95 (US) or type P1 (EN 143) dust masks. Use respirators and components tested and
approved under appropriate government standards such as NIOSH (US) or CEN (EU).

---

Section 9. PHYSICAL AND CHEMICAL PROPERTIES
Information on basic physical and chemical properties
a) Appearance Form: solid
b) Odour no data available
c) Odour Threshold no data available
d) pH no data available
e) Melting point/freezing no data available
point
f) Initial boiling point and no data available
boiling range
g) Flash point no data available
h) Evaporation rate no data available
i) Flammability (solid, gas) no data available
j) Upper/lower no data available
flammability or
explosive limits
k) Vapour pressure no data available
l) Vapour density no data available
m) Relative density no data available
n) Water solubility no data available
o) Partition coefficient: n- log Pow: 2,143
octanol/water
p) Autoignition no data available
temperature
q) Decomposition no data available
temperature
r) Viscosity no data available
s) Explosive properties no data available
t) Oxidizing properties no data available
Other safety information
no data available

---

Section 10. STABILITY AND REACTIVITY
Reactivity
no data available
Chemical stability
no data available
Possibility of hazardous reactions
no data available
Conditions to avoid
no data available
Incompatible materials
Strong bases
Hazardous decomposition products
Other decomposition products - no data available

---

Section 11. TOXICOLOGICAL INFORMATION
Information on toxicological effects
Acute toxicity
no data available
Skin corrosion/irritation
no data available
Serious eye damage/eye irritation
no data available
Respiratory or skin sensitization
no data available
Germ cell mutagenicity
no data available
Carcinogenicity
IARC: No component of this product present at levels greater than or equal to 0.1% is identified as
probable, possible or confirmed human carcinogen by IARC.
Reproductive toxicity
no data available
Specific target organ toxicity - single exposure
no data available
Specific target organ toxicity - repeated exposure
no data available
Aspiration hazard
no data available
Potential health effects
Inhalation May be harmful if inhaled. May cause respiratory tract irritation.
Ingestion May be harmful if swallowed.
Skin May be harmful if absorbed through skin. May cause skin irritation.
Eyes May cause eye irritation.
Signs and Symptoms of Exposure
To the best of our knowledge, the chemical, physical, and toxicological properties have not been
thoroughly investigated.
Additional Information
RTECS: Not available

---

Section 12. ECOLOGICAL INFORMATION
Toxicity
no data available
Persistence and degradability
no data available
Bioaccumulative potential
no data available
Mobility in soil
no data available
Results of PBT and vPvB assessment
no data available
Other adverse effects
no data available

---

Section 13. DISPOSAL CONSIDERATIONS
Waste treatment methods
Product
Offer surplus and non-recyclable solutions to a licensed disposal company. Contact a licensed
professional waste disposal service to dispose of this material. Dissolve or mix the material with a
combustible solvent and burn in a chemical incinerator equipped with an afterburner and scrubber.
Contaminated packaging
Dispose of as unused product.

---

Section 14. TRANSPORT INFORMATION
UN number
ADR/RID: - IMDG: - IATA: -
UN proper shipping name
ADR/RID: Not dangerous goods
IMDG: Not dangerous goods
IATA: Not dangerous goods
Transport hazard class(es)
ADR/RID: - IMDG: - IATA: -
Packaging group
ADR/RID: - IMDG: - IATA: -
Environmental hazards
ADR/RID: no IMDG Marine pollutant: no IATA: no
Special precautions for user
no data available

---

---

SECTION 15 - REGULATORY INFORMATION
N/A

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  1,2,3-三甲基-5-硝基-苯 在 sodium dithionite 作用下， 生成 3,4,5-三甲基苯胺
  参考文献：
  名称：

  Dollinsky et al., Journal of the Association of Official Agricultural Chemists, 1959, vol. 42, p. 709,716

  摘要：

  DOI：
• 作为产物：
  描述：

  3,4,5-三甲基苯胺 在 二苯基二硒醚 、 双氧水 作用下， 以99 %的产率得到1,2,3-三甲基-5-硝基-苯
  参考文献：
  名称：

  通过硝基苯和胺的脱芳-重芳偶联合成邻苯二胺的策略

  摘要：

  邻位-苯二胺是具有两个邻位N-取代基的芳香族分子，与生物活性材料的开发。这些衍生物目前是由邻-卤代硝基苯通过多步合成序列制备的。在这里，我们报告了一种概念上不同的方法，其中硝基苯和胺可以直接转化为邻-苯二胺，而不需要邻位-卤化并进行逐步合成操作。该策略在简单的蓝光照射下发生，并引入了另一种逆合成策略，其中胺偶联伴侣“似乎”取代了转变为邻位的硝基邻位位置，同时在一锅法中被还原和酰胺化。从机理上讲，该过程利用硝基苯转化为相应的单一氮烯，并经历一系列N-插入、电环扩环、胺加成、和电环收缩在形成邻位-苯二胺的过程中。

  DOI：

  10.1016/j.chempr.2023.10.008

文献信息

• FLUOROSURFACTANTS
  申请人：Hierse Wolfgang

  公开号：US20090312432A1

  公开（公告）日：2009-12-17

  The present invention relates to fatty acid alkanolamides or polyolamides containing at least one group Y, where Y stands for CF 3 —(CH 2 ) a —O—, SF 5 —, CF 3 —(CH 2 ) a —S—, CF 3 CF 2 S—, [CF 3 —(CH 2 ) a ] 2 N— or [CF 3 —(CH 2 ) a ]NH—, where a stands for an integer selected from the range from 0 to 5, or formula (I), where Rf stands for CF 3 —(CH 2 ) r —, CF 3 —(CH 2 ) r —O—, CF 3 —(CH 2 ) r —S—, CF 3 CF 2 —S—, SF 5 —(CH 2 ) r — or (CH 2 ) r ] 2 N—, [CF 3 —(CH 2 ) r ]NH— or (CF 3 ) 2 N—(CH 2 ) r —, B stands for a single bond, O, NH, NR, CH 2 , C(O)—O, C(O), S, CH 2 —O, O—C(O), N—C(O), C(O)—N, O—C(O)—N, N—C(O)—N, O—SO 2 or SO 2 —O, R stands for alkyl having 1 to 4 C atoms, b stands for 0 or 1 and c stands for 0 or 1, q stands for 0 or 1, where at least one radical from b and q stands for 1, and r stands for 0, 1, 2, 3, 4 or 5, to processes for the preparation of these compounds, and to uses of these surface-active compounds.

  本发明涉及含有至少一个基团Y的脂肪酸醇胺或多元胺，其中Y代表CF3—(CH2)a—O—，SF5—，CF3—(CH2)a—S—，CF3CF2S—，[CF3—(CH2)a]2N—或[CF3—(CH2)a]NH—，其中a代表从0到5的整数，或者公式(I)，其中Rf代表CF3—(CH2)r—，CF3—(CH2)r—O—，CF3—(CH2)r—S—，CF3CF2—S—，SF5—(CH2)r—或(CH2)r]2N—，[CF3—(CH2)r]NH—或(CF3)2N—(CH2)r—，B代表单键，O，NH，NR，CH2，C(O)—O，C(O)，S，CH2—O，O—C(O)，N—C(O)，C(O)—N，O—C(O)—N，N—C(O)—N，O—SO2或SO2—O，R代表具有1到4个碳原子的烷基，b代表0或1，c代表0或1，q代表0或1，其中至少一个来自b和q的基团代表1，r代表0，1，2，3，4或5，以及制备这些化合物的方法和这些表面活性化合物的用途。
• Quinazoline derivatives as antitumor agents
  申请人：Hennequin Francois Andre Laurent

  公开号：US20070088044A1

  公开（公告）日：2007-04-19

  The invention concerns quinazoline derivatives of Formula (I); wherein each of Q<1>, Q<2>, Z, R<1>, R<2>, R<3>, and m have any of the meanings defined in the description; processes for their preparation, pharmaceutical compositions containing them and their use in the manufacture of a medicament for use in the prevention or treatment of tumours which are sensitive to inhibition of erbB receptor tyrosin kinases.

  本发明涉及公式（I）的喹唑啉衍生物；其中Q <1>，Q <2>，Z，R <1>，R <2>，R <3>和m中的每个都具有描述中定义的任何含义；它们的制备过程，含有它们的制药组合物以及它们在制造用于预防或治疗对erbB受体酪氨酸激酶抑制敏感的肿瘤的药物中的使用。
• AMPHIPHILIC JANUS-DENDRIMERS
  申请人：Percec Virgil

  公开号：US20120308640A1

  公开（公告）日：2012-12-06

  The invention concerns compounds of the formula: X—(Y) t wherein: X is Formula (X), each Y is the same or different and is Formula (Y) —O—[CH 2 —CH(OH)—CH 2 —O—] m —H; or —C(OR 5 ) 3 ; R 1 , R 2 , R 3 , R 6 , R 7 , R 8 , R 9 , R 10 are each, independently, —(CH 2 CH 2 O) m —R 4 , —[CH 2 CH(OH)CH 2 O] n H, OR 11 , —O(CH 2 ) P R 13 , or —(CH 2 )R 12 ; each R 4 is independently OR 5 or OH; R 5 , R 11 and R 12 are each, independently, H or C 1 -C 30 alkyl; R 13 is —NH 3 + Cl − or —NHBoc; t is an integer from 2 to 6; m, n, and p are each, independently, an integer from 1 to 12; and each q, r, and s is 0 or 1 and the sum of q+r+s is at least 2.

  本发明涉及以下式的化合物：X—（Y）t其中：X是式（X），每个Y相同或不同，是式（Y）—O—[CH2—CH（OH）—CH2—O—]m—H；或—C（OR5）3；R1、R2、R3、R6、R7、R8、R9、R10各自独立地为—（CH2CH2O）m—R4，—[CH2CH（OH）CH2O]nH，OR11，—O（CH2）PR13或—（CH2）R12；每个R4独立地为OR5或OH；R5、R11和R12各自独立地为H或C1-C30烷基；R13为—NH3+Cl−或—NHBoc；t为2至6的整数；m、n和p各自独立地为1至12的整数；每个q、r和s为0或1，且q+r+s的总和至少为2。
• Synthesis of polysubstituted azepanes by dearomative ring expansion of nitroarenes
  作者：Rory Mykura、Raquel Sánchez-Bento、Esteban Matador、Vincent K. Duong、Ana Varela、Lucrezia Angelini、Rodrigo J. Carbajo、Josep Llaveria、Alessandro Ruffoni、Daniele Leonori

  DOI：10.1038/s41557-023-01429-1

  日期：——

  The synthesis of functionalized nitrogen heterocycles is integral to discovering, manufacturing and evolving high-value materials. The availability of effective strategies for heterocycle synthesis often biases the frequency of specific ring systems over others in the core structures of bioactive leads. For example, while the six- and five-membered piperidine and pyrrolidine are widespread in medicinal

  官能化氮杂环的合成对于发现、制造和开发高价值材料至关重要。有效的杂环合成策略的可用性通常会使生物活性先导核心结构中特定环系统的频率偏向于其他环系统。例如，虽然六元和五元哌啶和吡咯烷广泛存在于药物化学库中，但七元氮杂环庚烷基本上不存在，这留下了很大的三维化学空间区域。在这里，我们报告了一种通过光化学脱芳环扩展从简单硝基芳烃制备复杂氮杂环庚烷的策略，该策略以硝基基团转化为单线态氮烯为中心。该过程由蓝光介导，在室温下发生，并将六元苯环框架转变为七元环系统。随后的氢解只需两步即可提供氮杂环庚烷。我们通过合成几种哌啶药物的氮杂环庚烷类似物证明了该策略的实用性。
• Aromatic substitution. 48. Boron trifluoride catalyzed nitration of aromatics with silver nitrate in acetonitrile solution
  作者：George A. Olah、Alexander P. Fung、Subhash C. Narang、Judith A. Olah

  DOI：10.1021/jo00330a032

  日期：1981.8